INTRODUCTION
mRNA decay is a major mechanism controlling gene expression, and over the past several years significant advances have been made in elucidating mechanisms of the decay process. For most mRNAs, decay begins with the shortening of the poly(A) tail, after which there is a change in the nature of the mRNP, with proteins that facilitate mRNA decay (e.g., Lsm1-7, Pat1, Dhh1/p54/Rck, and Dcp1/2) replacing those associated with translation (e.g., poly(A)-binding protein and eIF4G) (Tharun and Parker, 2001) . For most yeast mRNAs and possibly most mammalian mRNAs, the next step involves loss of the cap and 5 0 -3 0 exonuclease-mediated decay of the mRNA body by Xrn1 (Stoecklin et al., 2005) . The proteins that facilitate and catalyze decapping and 5 0 -3 0 decay concentrate in discrete cytoplasmic foci termed ''processing bodies'' (P bodies, also called GW bodies [Jakymiw et al., 2005] ), and while there is evidence that decay can occur in these large RNP complexes it is not clear whether this process is restricted to P bodies or also occurs in submicroscopic complexes. In addition to this mechanism, there are reports of unstable mRNAs undergoing 3 0 -5 0 decay catalyzed by the cytoplasmic exosome (Chen et al., 2001; Mukherjee et al., 2002) . The binding of proteins like HuR to AU-rich elements can stabilize mRNA, whereas tristetraprolin, butyrate response factor 1, and others can promote 5 0 decay (Fenger-Gron et al., 2005) . Activation of different kinases can modulate the binding of stabilizing and destabilizing proteins, and in this manner regulate mRNA decay Briata et al., 2005; Chou et al., 2006) .
In contrast to these exonuclease-based pathways, a number of mRNAs are targeted by protein endonucleases that initiate decay by cleaving within the body of the mRNA while it is actively engaged by translating ribosomes. While endonucleases have been implicated in the decay of a number of mRNAs (Pastori et al., 1991; Binder et al., 1994; Wang and Kiledjian, 2000) , only three mRNA endonucleases have been linked to specific decay pathways: PMR1 (Chernokalskaya et al., 1998) , G3BP (Gallouzi et al., 1998) , and IRE-1 (Hollien and Weissman, 2006) . PMR1 was originally identified as a ribonuclease activity whose appearance on Xenopus liver polysomes after exposure to estrogen coincides with the posttranscriptional disappearance of serum protein mRNAs. Subsequent work showed that estrogen activates the decay of these mRNAs by inducing a 21-fold increase in the unit activity of the polysome-bound endonuclease (Cunningham et al., 2001) . PMR1 is distinct in that its sequence and structure bear no relationship to the known ribonucleases. Instead, it is a non-heme-containing member of the peroxidase gene family that, like most peroxidase gene products, is made as a larger precursor (PMR80) and processed to a smaller active form (PMR60) (Chernokalskaya et al., 1998) .
Our early work used whole animals and primary frog hepatocyte cultures to characterize much of the biology of PMR1. However, the technical difficulty of preparing primary frog hepatocyte cultures and their low transfection efficiency led us to explore selected mammalian cell lines as surrogates. Subsequent work showed that Xenopus PMR60 functions in a manner analogous to its native context when it is expressed in stably or transiently transfected cells, regardless of whether these cells express 
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Tyrosine Kinase Activation of mRNA Decay (Bremer et al., 2003) or do not express ) the mammalian ortholog of this protein. Using deletion mutants of a catalytically inactive form of Xenopus PMR1 (PMR60 ), we identified specific polysome targeting domains, and experiments with catalytically active PMR60 showed that both polysome targeting and translation of its substrate mRNA are required for endonucleasemediated mRNA decay . Interestingly, a similar mechanism was recently described for IRE-1-mediated endonuclease decay of a specific set of endoplasmic reticulum-associated mRNAs in response to the accumulation of unfolded proteins (Hollien and Weissman, 2006) . Y650 in the C terminus of PMR60 plays a critical role in targeting this protein to polysomes. Phosphorylation at this tyrosine generates a consensus SH2 ligand that is required for PMR60 targeting to polysomes . Changing this amino acid to phenylalanine or treating cells with the general tyrosine kinase inhibitor AG18 inactivated polysome targeting and endonuclease-mediated decay. Here, we identify c-Src as the PMR60 tyrosine kinase and show that its activation by EGF binding to EGFR results in rapid tyrosine phosphorylation of the mRNA endonuclease.
RESULTS

c-Src Interacts with and Phosphorylates PMR60
In Vitro and In Vivo PMR60 participates in two major complexes: an 680 kDa mRNP (complex I), which is the polysome-bound form containing the endonuclease and its substrate mRNA , and an 140 kDa complex (complex II) that is the precursor to complex I . Tyrosine phosphorylation occurs in complex II, and a doublet product was seen when PMR60-containing complexes recovered from glycerol gradient fractions of this complex were probed with the phosphotyrosine monoclonal antibody PY20, whereas only a single band was observed when the same fractions were probed for the N-terminal myc tag on PMR60 . Because tyrosine kinases commonly undergo autophosphorylation, we asked whether the smaller band identified with PY20 might be a tyrosine kinase bound to PMR60 . In the experiment in Figure 1A, To confirm that PMR60 is a substrate for c-Src, we expressed His-PMR60 in bacteria ( Figure 1B , left panel) and incubated increasing amounts of recombinant protein with recombinant c-Src and [g-32 P]ATP. Autophosphorylation of c-Src was again evident ( Figure 1B, right panel) , as was the increased labeling of His-PMR60 with increasing amounts of input protein. The ability of c-Src to specifically label Y650 was tested using a peptide containing this site. In Figure 1C , recombinant c-Src was added to the indicated peptide that was synthesized without (peptide) or with a phosphate (PY-peptide) on the tyrosine corresponding to Y650. Autophosphorylation of c-Src was again seen and only the unphosphorylated form of the peptide was labeled, thus confirming that PMR60 is a substrate for c-Src.
Reciprocal immunoprecipitation was used to examine the in vivo interaction of c-Src with PMR60
( Figure 1D ). U2OS osteosarcoma cells were transfected with plasmids expressing myc-tagged PMR60 or GFP, and protein complexes recovered by immunoprecipitation with monoclonal antibody to the myc tag (left panels) or a polyclonal antibody to c-Src (right panels) were analyzed by western blot. c-Src was recovered with PMR60
, but not GFP (lanes 3 and 4). Conversely, PMR60
was recovered with anti-Src but GFP was not (lanes 7 and 8), thus confirming c-Src as the kinase activity recovered in Figure 1A . The functional impact of this interaction is shown in Figure 1E , where treating U2OS cells for 60 min with the selective c-Src inhibitor PP2 blocked tyrosine phosphorylation of PMR60 whereas its inactive congener (PP3) had no effect.
Activated c-Src Catalyzes Tyrosine Phosphorylation of PMR60
c-Src is elevated in many cancers (Irby and Yeatman, 2000) and cancer-derived cell lines. To examine further the role of activated c-Src in catalyzing the phosphorylation of PMR60 in vivo, we used a line of COS-1 cells that has 53 less c-Src than U2OS cells ( Figure 2A ). These c-Src and [g- 
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Tyrosine Kinase Activation of mRNA Decay were transfected with plasmids expressing PMR60 plus empty vector, a dominant-negative form of c-Src (DN-Src), or a constitutively active form of c-Src (CA-Src), and the immunoprecipitated protein was examined as in Figure 1 to determine the impact of each form of c-Src on tyrosine phosphorylation ( Figure 2B ). As one might anticipate from the reduced amount of c-Src, there was no evidence for tyrosine phosphorylation in vectortransfected cells. Similarly, tyrosine phosphorylation was not observed in cells expressing DN-Src, but PMR60 was phosphorylated in cells expressing CA-Src. In the right panel, the recovery of each of these forms of c-Src with PMR60
was determined by western blot. While somewhat more DN-Src was present in the input sample in three independent experiments, significantly more of this protein was recovered with PMR60 than CA-Src. These data suggest that the functional interaction of c-Src with PMR60 is transient and the complex dissociates after PMR60 is phosphorylated. Among the numerous pathways in which c-Src participates, the best known is its activation by EGF binding to the EGF receptor (EGFR). c-Src interacts directly with EGFR, and EGF binding activates the reciprocal phosphorylation of both proteins to initiate downstream events. To determine whether this upstream signaling process induces c-Src phosphorylation of PMR60 , COS-1 cells were first cultured in serum-free medium to reverse the downregulation of EGFR caused by prolonged growth in serum-containing medium (Wong et al., 2002) . Changes in tyrosine phosphorylation of immunoprecipitated PMR60
were then followed as a function of time after EGF addition ( Figure 2C ). Prior to adding EGF, there is little evidence for tyrosine phosphorylation of PMR60 (lane 1). Tyrosine phosphorylation is induced within 10 min and is maintained over the 60 min time course examined here, thus indicating that EGF binding to its receptor activates the phosphorylation of PMR60
. To confirm that c-Src is the responsible kinase, this was repeated with cells that were treated for 30 min with PP2 or PP3 prior to adding EGF ( Figure 2D ). PP3 had no impact on tyrosine phosphorylation of PMR60 but this was inhibited by PP2, thus confirming that EGF activates c-Src to phosphorylate PMR60 .
The Interaction with c-Src Involves SH3-and SH2-Binding Sites on PMR60
To identify features of PMR60 that define its interaction with c-Src, we employed a battery of deletion constructs (diagrammed in Figure 3A ) that were used previously to map functional domains of PMR60 (Yang and 
Tyrosine Kinase Activation of mRNA Decay Yang et al., 2006) . In the experiment in Figure 3B , COS-1 cells were cotransfected with GFP or each of the indicated PMR60 deletion constructs and wild-type c-Src (WT-Src), and western blots of the recovered proteins were probed with antibodies to the myc tag on PMR60
and GFP, and c-Src. WT-Src was used here because more of this form of the enzyme is recovered with PMR60 than CA-Src (e.g., Figure 2B and data not shown). Removal of the N-terminal 50 amino acids had no impact on the recovery of c-Src (lane 3), and binding was reduced after deletion of the N-terminal 100 amino acids (lane 4) and was lost after deletion of the N-terminal 150 amino acids (lane 5). The C-terminal 50 amino acids lie just downstream of Y650, and deleting this portion of the protein had no impact on the recovery of c-Src (lane 6). However, recovery of c-Src was lost when the C-terminal 100 amino acids that include Y650 were deleted (lane 7). To determine whether Y650 is required for the binding of c-Src to PMR60
, the experiment in Figure 3B was repeated with cells transfected with wild-type PMR60 or the Y650F mutation , and results in Figure 3C show that indeed Y650 is required for the binding of c-Src to PMR60 . The SH3 domain of c-Src binds to proline-rich sequences, and the N-terminal deletion that results in loss of c-Src binding includes a pair of PPXXP motifs spanning amino acids 261-265 and 269-273. To determine whether either or both of these are involved in the interaction with c-Src, two prolines in each repeat (P262 and P265; P270 and P273) were changed to alanine, and the resulting constructs were cotransfected with WT-Src. Results in Figure 3D show that neither of these mutations affect 
Tyrosine Kinase Activation of mRNA Decay PMR60 expression or its recovery with myc antibody, and both of these mutations prevent the recovery of c-Src with PMR60
. Western blotting of recovered PMR60 with PY20 confirmed that tyrosine phosphorylation was lost with each mutation ( Figure 3E ). Together, these data demonstrate that the interaction of c-Src with PMR60 involves both of the proline-rich SH3-binding domains in the N-terminal 100 amino acids and the tyrosine phosphorylation site at Y650.
c-Src Activates PMR60
Targeting to Polysomes and mRNA Decay The signature feature of PMR60-mediated mRNA decay is the formation of a polysome-bound complex of the tyrosine-phosphorylated protein with its substrate mRNA. If c-Src is the responsible kinase, then the active form of this enzyme should activate polysome targeting in cells with little c-Src whereas inactive forms should not. The COS-1 cells used in the previous experiments were cotransfected with PMR60
and GFP plus empty vector or plasmids expressing CA-Src, DN-Src, or one lacking kinase activity (kinase inactive, KI-Src). The expression of each of these is shown in Figure 4A . Cytoplasmic extracts of these cells were applied to discontinuous sucrose density gradients, and the top, mRNP (interface), and polysome (pellet) fractions were analyzed as before for PMR60
, GFP, and ribosomal protein S6 ( Figure 4B ). In cells that are cotransfected (B) The extracts from (A) were separated on 10% plus 35% sucrose step gradients, and fractions recovered from the top, interface (mRNP), and pellet (polys) adjusted to equal volumes were analyzed by western blotting with myc antibody. The sedimentation of polysomes to the bottom of each gradient was confirmed by reprobing the blot with antibody to ribosomal protein S6.
(C) COS-1 cells were transfected with empty vector or plasmids expressing catalytically active PMR60, albumin, and luciferase mRNA. Each set was also transfected with the c-Src plasmids in (A), and cytoplasmic extracts were analyzed for protein expression by western blot.
(D) The impact of these proteins on steady-state levels of albumin and luciferase mRNA was determined by RNase protection assay using the mixed probe shown in lane 2. The relative amount of albumin mRNA normalized to luciferase mRNA is shown beneath the autoradiogram. Lane 1 (M) contains a ladder of HinfI-digested fX174 DNA.
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Tyrosine Kinase Activation of mRNA Decay with empty vector, the majority of PMR60 remained at the top of the gradient (lanes 1-3) , and PMR60 behaves similarly in cells expressing DN-Src and KI-Src. The converse is seen in cells expressing CA-Src, with the majority of PMR60 now sedimenting with polysomes. These data confirm that phosphorylation by c-Src activates polysome targeting by PMR60 . To confirm that c-Src-activated polysome targeting activates PMR60-mediated mRNA decay, COS-1 cells were transfected as above with the addition of plasmids expressing target (albumin) and nontarget (luciferase) mRNAs . The expression of PMR60, c-Src, and luciferase is shown in Figure 4C , and Figure 4D shows the impact of these treatments on albumin and luciferase mRNA assayed by RNase protection. In cells without added c-Src (lanes 4 and 5) or expressing DN-Src (lanes 8 and 9), there was no evidence for PMR60-mediated decay of albumin mRNA. In contrast, CA-Src activated PMR60-mediated decay of albumin mRNA without affecting luciferase mRNA (lanes 6 and 7).
DISCUSSION
The general decay process involving decapping and exonuclease degradation involves mRNAs that are no longer engaged by translating ribosomes (Coller and Parker, 2005; Parker and Song, 2004) . This contrasts with endonuclease-mediated mRNA decay, which involves targeting of a specific endonuclease to translating substrate mRNA Hollien and Weissman, 2006) . Because decapping and exonuclease decay is the default pathway, there must be a fundamental code that distinguishes mRNAs that are targeted by endonuclease decay. This code likely has sequence and/or structure determinants in the mRNA itself that engage a specific cohort of RNA-binding proteins that in turn recruit the mRNA endonuclease. Previous work from our lab showed that in Xenopus liver PMR60 initiates endonuclease-mediated decay when bound to polysomes (Cunningham et al., 2001) , and decay requires active translation of its substrate mRNA . The first major insight into the selectivity of this process was the discovery that endonuclease-mediated decay required the phosphorylation of PMR60 on a specific tyrosine residue (Y650) within a domain that is required for targeting to its translating substrate mRNA . The resulting phosphopeptide sequence is similar but is not an exact match to any of the mapped SH2 ligands (Liu et al., 2006) , indicating that a yet-to-be-identified SH2 domain protein is involved in recruiting PMR60 to polysomes.
A number of serine/threonine kinases have been linked to mRNA decay (e.g., Schmidlin et al. [2004] , Rutault et al. [2001] , and Chen et al. [1998] ), but this has not been the case for tyrosine kinases. Because tyrosine phosphorylation is required to ''license'' PMR60 targeting to polysomes, the goal of this study was to identify the responsible kinase. The key to finding c-Src was the observation that PMR60 recovered from glycerol gradient fractions yielded a single band when probed with antibody to its epitope tag and two bands when probed with PY20. Because tyrosine kinases commonly form a complex with their substrate and undergo autophosphorylation, we reasoned that the second (smaller) band might be the PMR60 kinase. This was confirmed in Figure 1 , where the size of this kinase matched that of c-Src, and in subsequent experiments that showed c-Src binds to and phosphorylates PMR60 in vitro and in vivo. The in vivo phosphorylation of PMR60 can be blocked with the c-Src inhibitor PP2, but not its inactive congener ( Figures  1E and 2D) . These data plus those in Figure 4 , which show that active c-Src is required for both targeting of PMR60 to polysomes and PMR60-mediated mRNA decay, confirm that c-Src plays an essential role in endonucleasemediated mRNA decay.
The use of various forms of c-Src and a line of COS-1 cells with relatively little c-Src facilitated the mapping of interacting sites on PMR60. The SH2 and SH3 domains of c-Src bind phosphotyrosine and proline-rich ligands, respectively, and results in Figure 3 show that these features of PMR60 are required for its interaction with the kinase. PMR60
has two repeating PPXXP motifs within an N-terminal portion of the protein, each of which is required for its interaction with c-Src. The recovery of c-Src with PMR60 was lost when either of these was changed to PAXXA, indicating that the extended sequence is likely involved in c-Src binding. As noted above, c-Src was not recovered with Y650F PMR60 . c-Src is commonly elevated in cancer, and enhanced activity of Src-mediated signal transduction is a recurring theme in malignancy (Ishizawar and Parsons, 2004) . EGF binding to EGFR is one of the best characterized processes that activates c-Src, and results in Figures 2C  and 2D show that EGF rapidly activates c-Src-mediated phosphorylation of PMR60
. The finding that licensing of PMR60 to target to polysomes is an early event in signaling through c-Src raises the interesting and important possibility that elevation of c-Src might enhance the growth of malignant cells by increasing the selective degradation of mRNAs that are targeted by endonucleasemediated decay. This will be addressed by work in progress aimed at identifying the mRNAs present in polysome-bound complexes with PMR60 .
EXPERIMENTAL PROCEDURES
Plasmid Constructs
The preparation of plasmids expressing catalytically active PMR60, catalytically inactive PMR60 , Y650F mutant, and PMR60 deletions was described previously . The mutations P262,265A and P270,273A were generated by site-directed mutagenesis of the proline residues at positions 262, 265, 270, and 273 using the QuikChange Site-Directed Mutagenesis Kit (Stratagene 
Antibodies
Monoclonal antibody to the c-Myc epitope tag (9E10), myc antibodycoupled beads, and antibodies to GFP (B2), c-Src (SRC2 and B-12), and ribosomal protein S6 (E13) were purchased from Santa Cruz Biotechnology. PY20 was purchased from BD Biosciences, and horseradish peroxidase-coupled rabbit anti-mouse IgG and goat anti-rabbit IgG were purchased from Santa Cruz.
Cell Culture COS-1 cells were cultured in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum and 2 mM glutamine. U2OS cells were cultured in McCoy's 5A medium plus 10% fetal bovine serum. For most experiments, 2.5 3 10 6 cells in log phase growth were transfected with 10 mg (total) of plasmid DNA by using Lipofectamine (Invitrogen) following the manufacturer's protocol. Unless otherwise indicated, cells were collected 40 hr after transfection. To study EGF activation of c-Src, COS-1 cells were serum starved for 16 hr prior to adding 100 ng/ml EGF. To inhibit c-Src in these cells, 10 mM PP3 or PP2 was added to the culture 30 min before addition of EGF.
Preparation of Cell Extracts
Cytoplasmic extracts were prepared as described previously . Briefly, cells were washed twice with icecold phosphate-buffered saline, then suspended in cell lysis buffer (10 mM HEPES-KOH [pH 7.5], 10 mM KCl, 5 mM MgCl 2 , 50 mM NaF, 0.5% Nonidet P-40 [v/v], 2 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 25 ml/ml protease inhibitor mixture [Sigma], 10 ml/ml phosphatase inhibitors [Sigma] , and 10 ml/ml RNaseOUT [Invitrogen]). After incubation for 15 min on ice, the cells were homogenized with 30 strokes of a Dounce homogenizer (A pestle), and the homogenate was centrifuged for 15 min at 2000 3 g. Polysomes and mRNP complexes were separated on discontinuous sucrose gradients containing 1 ml each of 10% and 35% (w/v) sucrose in the buffers described above (Schoenberg and Cunningham, 1999) . Postmitochondrial extract was fractionated by sedimentation for 1 hr at 147,000 3 g in a Sorvall Discovery M120 SE ultracentrifuge using an S55S-1123 rotor. Polysomes were collected from the bottom of the tube, and mRNP complexes were collected at the interface between the 10% and 35% sucrose layers.
Expression of Recombinant PMR60
The plasmid pET32b-PMR was transformed into E. coli BL21(DE3). Cells were grown to an optical density (OD) 600 of 1.2 and induced with 0.5 mM IPTG for 4 hr at 37 C. Cells were lysed by sonication in the buffer containing 13 PBS, 5 mM EDTA, 5 mM DTT, 1 mg/ml lysozyme, and 1 mM PMSF. After centrifugation, the pellets were extensively washed with 13 PBS, 5 mM EDTA, 5 mM DTT, 2 M urea, and 2% Triton X-100, then dissolved in 20 mM NaH 2 PO 4 , 500 mM NaCl, 6 M guanidine-HCl, and 2 mM b-mercaptoethanol [pH 8.0]. The clarified lysate was loaded onto HiTrap chelating HP column (Amersham Biosciences). After extensive washing with 20 mM NaH 2 PO 4 , 500 mM NaCl, and 10 mM imidazole [pH 7.5], bound proteins were eluted with a linear gradient of 10-500 mM imidazole. The purified proteins were renatured in 20 mM Tris-HCl [pH 8.5], 1 mM reduced glutathione, 0.1 mM oxidized glutathione, 9.6 mM NaCl, and 0.4 mM KCl and were further purified by ion-exchange chromatography on a fast-flow DEAE-Sepharose column.
Immunoprecipitation and Western Blot Analysis
For immunoprecipitation with myc antibody, cell lysates were incubated with monoclonal antibody-coupled beads on a rocking platform for 3 hr at 4 C. For immunoprecipitation with rabbit anti-Src antibody, cell lysates were incubated with antibody for 3 hr at 4 C followed by 20 ml of protein A agarose (Santa Cruz Biotechnology) and incubation for 1 hr on a rocking platform at 4 C. The beads were washed four times with IPP150 buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 0.1% NP-40) and suspended in SDS-PAGE sample buffer. For western blot analysis, the immunoprecipitates were separated on a 10% SDS-PAGE gel and electroblotted onto Immobilon-P membrane (Millipore). The membrane was blocked for 1 hr at room temperature in 5% nonfat dry milk in TBST buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 0.1% NP-40), then incubated with the primary antibody for 4 hr at room temperature, washed, and incubated with horseradish peroxidase-conjugated secondary antibody for 1 hr. Blots were developed with SuperSignal west pico chemiluminescent substrate (Pierce).
In Vitro Kinase Assays HPLC-purified N-terminal biotin-labeled peptides containing the tyrosine phosphorylation site of PMR60 (ARDGDRFFYEQP) without or with phosphotyrosine at position 9 (corresponding to Y650) were obtained from American Peptide Company (Sunnydale, CA). Six units of purified recombinant c-Src (Upstate Biotechnology) was incubated with 250 mmol of each synthetic peptide or different amounts of recombinant PMR60 dissolved in 50 ml of 25 mM Tris-HCl (pH 7.5), 30 mM MgCl 2 , 12.5 mM MnCl 2 , 1 mM EGTA, 60 mM sodium orthovanadate, and 1 mM dithiothreitol. Reactions were initiated by adding 1 ml of [g-32 P]ATP (3000 Ci/mmol, PerkinElmer) and were incubated for 30 min at 30 C. The reaction was stopped by the addition of SDS sample buffer, and phosphorylated samples separated by SDS-PAGE were visualized by phosphorimager.
Ribonuclease Protection Assay
Paired cultures of 8 3 10 5 cells each were transiently transfected with plasmids expressing albumin and luciferase mRNA plus empty vector (pcDNA3), or plasmid expressing catalytically active myc-PMR60. To determine the impact of c-Src on mRNA decay, each set was also transfected with pUSEamp (the empty vector for c-Src) or plasmids expressing CA-or DN-Src. Total RNA was isolated with TRIzol reagent (Invitrogen). The antisense albumin riboprobe was prepared with the MAXIscipt In Vitro Transcription Kit (Ambion) using T7 promoter from a pcRII-Topo plasmid containing exons 14 and 15 of albumin cDNA. The antisense firefly luciferase riboprobe was synthesized with T3 promoter from a pBluescript(SK) plasmid containing the first 153 nucleotides of firefly luciferase cDNA. Ribonuclease protection assay was done as described previously with 5 mg of total RNA hybridized to 600 pg of each riboprobe using the Ribonuclease Protection Assay III Kit (Ambion). Protected probe was separated on a denaturing 6% polyacrylamide-urea gel and quantified by phosphorimager analysis.
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